Warren J. Machan - 28 Oct 2024 Form 3 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
Interim CFO
Signature
/s/ Mojirade James, as attorney-in-fact for Warren J. Machan pursuant to power of attorney filed herewith
Issuer symbol
AVNS
Transactions as of
28 Oct 2024
Net transactions value
$0
Form type
3
Filing time
06 Nov 2024, 16:52:19 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AVNS Common Stock 9,351 28 Oct 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AVNS Employee Stock Options (right to buy) 28 Oct 2024 Common Stock 1,600 $37.88 Direct F1
holding AVNS Employee Stock Options (right to buy) 28 Oct 2024 Common Stock 4,994 $45.47 Direct F2
holding AVNS Employee Stock Options (right to buy) 28 Oct 2024 Common Stock 5,609 $45.53 Direct F3
holding AVNS Employee Stock Options (right to buy) 28 Oct 2024 Common Stock 9,870 $29.48 Direct F4
holding AVNS Employee Stock Option (right to buy) 28 Oct 2024 Common Stock 8,979 $36.74 Direct F5
holding AVNS Employee Stock Option (right to buy) 28 Oct 2024 Common Stock 7,305 $52.10 Direct F6
holding AVNS Employee Stock Options (right to buy) 28 Oct 2024 Common Stock 16,379 $43.59 Direct F7
holding AVNS Employee Stock Option (right to buy) 28 Oct 2024 Common Stock 10,501 $28.87 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vested 30% on November 7, 2015, 30% on November 7, 2016, and 40% on November 7, 2017.
F2 These options vested 1/3 on each of March 5, 2018, March 5, 2019 and March 5, 2020.
F3 These options vested 30% on May 5, 2016, 30% on May 5, 2017, and 40% on May 5, 2018.
F4 These options vested 30% on May 5, 2017, 30% on May 5, 2018, and 40% on May 5, 2019.
F5 These ooptions vested 30% on May 3, 2018, 30% on May 3, 2019, and 40% on May 3, 2020.
F6 These options vested 30% on May 8, 2019, 30% on May 8, 2020, and 40% on May 8, 2021.
F7 These options vested 30% on May 8, 2020, 30% on May 8, 2021, and 40% on May 8, 2022.
F8 These options vested 30% on May 7, 2021, 30% on May 7, 2022 and 40% on May 7, 2023.

Remarks:

The reporting person first became subject to Section 16 as an officer of the Issuer on October 31, 2014; ceased to be subject to Section 16 in 2018; again became subject to Section 16 in 2019; ceased to be subject to Section 16 in 2020; and retired effective April 1, 2021. The reporting person became a Section 16 officer again on October 28, 2024 and therefore is filing this Form 3.